The role of beta cell regeneration in type 2 diabetes

The role of beta cell regeneration in type 2 diabetes
Credit: Thinkstock

The World Health Organization (WHO) has declared type 2 diabetes as the epidemic of the 21st century. A study is focusing on understanding the mechanisms underlying insulin resistance and the role of beta-cell regeneration.

Type 2 diabetes develops through a step-wise process, starting by the inability of the body to use insulin effectively which causes to produce more insulin in an attempt to compensate for this phenomenon. Eventually, the beta cells become exhausted and cannot produce enough insulin to overcome and at this point, this condition can progress to diabetes.

A substantial decrease in the number of beta cells due to extensive cell death or decreased proliferation, and/or an impairment of are considered the most likely mechanisms underlying type 2 diabetes. The European BCELL-T2D is aiming to delineate these mechanisms and study the potential of beta- in therapy.

To achieve this, scientists have characterised a mouse model carrying a mutation in the receptor that binds the fat cell-specific hormone leptin. These animals are prone to obesity and type 2 diabetes.

Results so far indicate that insulin resistance starts at 4–9 weeks of age, progresses to frank diabetes (10–18 weeks of age) and finally to advanced diabetes and its complications (after 19 weeks of age). Assessment of the beta-cell mass at each stage has shown an initial expansion in the insulin compensatory phase that disappears along the evolution of the disease.

As a therapeutic intervention, scientists are looking to overcome the proliferation shortage of beta cells by providing cyclin C, a protein that controls cell cycle entry. Ongoing research will determine if sustained beta- has the potential to prevent diabetes debut.

By studying the type 2 diabetes mouse model, scientists have revealed novel insight into the disease development and pathophysiology. Project findings hold great potential of being translated into new therapies in order to prevent and treat this devastating disease and its complications.

add to favorites email to friend print save as pdf

Related Stories

Compounds that trigger beta cell replication identified

Feb 25, 2009

Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput ...

Recommended for you

Economic burden of prediabetes up 74 percent over five years

20 hours ago

The economic burden of diabetes in America continues to climb, exceeding more than $322 billion in excess medical costs and lost productivity in 2012, or more than $1,000 for every American, according to a study being published ...

Gynoid fat resists metabolic risks of obesity

Nov 19, 2014

(HealthDay)—The differences in the developmental profiles of upper-body and lower-body fat depots may explain their opposing associations with obesity-related metabolic disease, according to research published ...

Treating diabetes one meal at a time

Nov 19, 2014

Recent estimates project that as many as one in three American adults will have diabetes in 2050. The American Diabetes Association observes November as American Diabetes Month, and this year's theme is America ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.